aminosalicylic acid has been researched along with probenecid in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 7 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| CLOWATER, RA; RILEY, C; SHANE, SJ | 1 |
| RUDBERG, R | 1 |
| CROFTON, JW; MCLEOD, JA; TURNBULL, FW | 1 |
| REKOLA, J | 1 |
| CARR, DT; KARLSON, AG | 1 |
| FURUTA, M | 1 |
| DE FOCKERT, JA | 1 |
| SNEGIREV, EA | 1 |
| JANSZEN, H | 1 |
| FRIEDMAN, MM; RIEBER, CW; SALINE, M | 1 |
| BOGER, WP; ISRAEL, HL; MICK, F | 1 |
| GROSS, R; HEBEL, R; HERTEL, H; MATIS, P | 1 |
| CARVALHO, LS | 1 |
| BRIDGE, EV; CARR, DT | 1 |
| HESS, EV; SIMMONDS, FA | 1 |
| AMATUZIO, DS; BREITENBUCHER, RB; FALK, A | 1 |
| SANZ, MC; WILHELMI, E | 1 |
| STEINLIN, H; WILHELMI, E | 1 |
| BOGER, WP; PITTS, FW | 1 |
| BOGER, WP; GALLAGHER, ME; PITTS, FW | 1 |
| Jung, JA; Parvez, MM; Shin, HJ; Shin, JG | 1 |
2 review(s) available for aminosalicylic acid and probenecid
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
26 other study(ies) available for aminosalicylic acid and probenecid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Failure of P-(di-n-propylsulfamyl)-benzoic acid (benemid) to influence p-aminosalicylic acid blood levels.
Topics: Aminosalicylic Acid; Benzoic Acid; Probenecid; Tuberculosis | 1953 |
[Probenecid and its effects on chemotherapeutic and antibiotic agents].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Inactivation, Metabolic; Penicillins; Probenecid | 1953 |
The use of benemid to enhance blood-levels of sodium para-aminosalicylate (PAS).
Topics: Aminosalicylic Acid; Antitubercular Agents; Probenecid; Sodium; Sodium, Dietary; Tuberculosis; Tuberculosis, Pulmonary | 1953 |
On the effect of benemid on the concentration of aminosalyl in the blood.
Topics: Aminosalicylic Acid; Probenecid | 1953 |
The effect of probenecid on the therapeutic efficacy of PAS on experimental tuberculosis in guinea pigs.
Topics: Aminosalicylic Acid; Animals; Guinea Pigs; Probenecid; Tuberculosis | 1954 |
The effects of benzochinon monosemicarbazon, PAS and PAS combined with benemide on experimental tuberculosis in mice.
Topics: Aminosalicylic Acid; Animals; Mice; Probenecid; Quinones; Tuberculosis | 1953 |
[The use of benemid in the administration of para-aminosalicylic acid].
Topics: Aminosalicylic Acid; Probenecid | 1957 |
[The action of ethamide on the excretion of p-aminosalicylic acid by the kidneys].
Topics: Aminosalicylic Acid; Biological Transport; Body Fluids; Ethoxzolamide; Kidney; Probenecid | 1962 |
The effect of benemid [p-(di-n-propylsulfamyl)benzoic acid] on blood levels of PAS.
Topics: Aminosalicylic Acid; Benzoic Acid; Probenecid | 1951 |
Plasma concentrations of para-aminosalicylic acid (PAS) after oral and rectal administration as influenced by p-(di-n-propylsulfamyl)-benzoic acid (benemid).
Topics: Administration, Rectal; Aminosalicylic Acid; Benzoic Acid; Humans; Probenecid | 1951 |
The effect of the prolonged administration of p-(di-n-propylsulfamyl)-benzoic acid (benemid) upon plasma concentrations of para-aminosalicylic acid.
Topics: Aminosalicylic Acid; Benzoic Acid; Probenecid | 1951 |
[Increase of penicillin and PAS blood levels through excretion inhibitory substances (carinamide and benamide)].
Topics: Aminosalicylic Acid; Biological Transport; Body Fluids; Penicillins; Probenecid; Sulfonamides | 1951 |
[Probenecid as a useful reinforcer of the bacteriostatic action of para-aminosalicylic acid].
Topics: Aminosalicylic Acid; Probenecid | 1951 |
Concentration of PAS and tuberculostatic potency of serum after administration of PAS with and without benemid.
Topics: Aminosalicylic Acid; Probenecid | 1952 |
Benemid and sodium PAS.
Topics: Aminosalicylic Acid; Ions; Probenecid; Sodium; Sodium, Dietary; Tuberculosis; Tuberculosis, Pulmonary | 1952 |
The effect of probenecid (benemid) in enhancing para-aminosalicylic acid concentrations in the blood.
Topics: Aminosalicylic Acid; Probenecid | 1952 |
[Retardation of elimination of paraminosalicylic acid by benemid].
Topics: Aminosalicylic Acid; Biological Transport; Probenecid | 1952 |
[Effects of benemid on the PAS blood level; its therapeutic use in tuberculosis].
Topics: Aminosalicylic Acid; Probenecid; Tuberculosis | 1952 |
Influence of p-(di-n-propylsulfamyl)-benzoic acid, "benemid", on para-aminosalicylic acid (PAS) plasma concentrations.
Topics: Amino Acids; Aminosalicylic Acid; Benzoic Acid; Leadership; Probenecid; Salicylic Acid | 1950 |
Benemid and carinamide: comparison of effect on para-aminosalicylic acid (PAS) plasma concentrations.
Topics: Amino Acids; Aminosalicylic Acid; Probenecid; Salicylic Acid; Sulfonamides | 1950 |
Evaluation of
Topics: Aminosalicylic Acid; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Cimetidine; Drug Interactions; HEK293 Cells; Humans; Ibuprofen; Liver-Specific Organic Anion Transporter 1; Naproxen; Octamer Transcription Factor-1; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Organic Cation Transporter 2; Probenecid; Proton Pump Inhibitors; Quinidine; Rifampin; Verapamil | 2017 |